IL18 and metabolic syndrome: The G-allele associated significantly with lower IL-18 levels in patients both with and without T2DM (p = 0.006 and p = 0.003, respectively) (Figure 3A), and in patients with and without MetS (p = 0.001 and p = 0.005, respectively) (Figure 3B).